Feasibility of multimodal molecular characterization of the androgen receptor (AR) in circulating tumor cells (CTCs) from patients with castrate-resistant prostate cancer (CRPC).

被引：0
|
作者：
VanderWeele, David James [1 ]
Isikbay, Masis [1 ]
Reyes, Edwin [1 ]
Duggan, Ryan [1 ]
Wyche, Alicia J. [1 ]
Stadler, Walter Michael [1 ]
Vander Griend, Donald [1 ]
Szmulewitz, Russell Zelig [1 ]
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 04期
关键词：
D O I：
10.1200/jco.2014.32.4_suppl.133
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
133
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Evaluation of PTEN status in circulating tumor cells (CTCs) and matched tumor tissue from patients with castrate-resistant prostate cancer (CRPC)
    Punnoose, Elizabeth
    Tucker, Eric
    Marrinucci, Dena
    Amler, Lukas C.
    Koeppen, Hartmut
    Patel, Premal H.
    Yan, Yibing
    Riisnaes, Ruth
    Attard, Gerhardt
    De Bono, Johann Sebastian
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [2] Evaluation of PTEN status in circulating tumor cells (CTCs) and matched tumor tissue from castrate-resistant prostate cancer (CRPC) patients
    Punnoose, Elizabeth
    Tucker, Eric
    Szafer-Glusman, Edith
    Zhu, Jin
    Marrinucci, Dena
    Louw, Jessica
    Lee, Florence
    Kitchen, Mikel
    Bales, Natalee
    Amler, Lukas
    Koeppen, Hartmut
    Patel, Premal
    Yan, Yibing
    Riisnaes, Ruth
    Attard, Gerhardt
    de Bono, Johann
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [3] Non-enrichment-based method for analysis of androgen receptor expression in circulating tumor cells (CTCs) in patients with metastatic castrate-resistant prostate cancer.
    Gross, Mitchell E.
    Lazar, Daniel
    Cho, Edward H.
    Luttgen, Madelyn
    Metzner, Thomas
    Uson, Maria Loressa
    Torrey, Melissa Louise
    Kuhn, Peter
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [4] Recovery and characterization of circulating tumor cells (CTCs) in cryopreserved metastatic castrate-resistant prostate cancer (mCRPC) patient samples
    Lu, David
    Harvey, Melissa
    Madan, Ravi
    Heery, Christopher
    Marte, Jennifer
    Beasley, Sharon
    Landers, Mark
    Krupa, Rachel
    Louw, Jessica
    Wahl, Justin
    Bales, Natalee
    Marrinucci, Dena
    Schlom, Jeffrey
    Gulley, James
    Dittamore, Ryan
    [J]. CANCER RESEARCH, 2015, 75
  • [5] Circulating tumor cells (CTCs) N-terminal androgen receptor expression to identify patients (pts) with castrate resistant prostate cancer (CRPC) who are more sensitive to chemotherapy.
    Slovin, Susan F.
    Knudsen, Karen E.
    Halabi, Susan
    Carbone, Emily
    Fernandez, Celina
    Chen, Yu
    Autio, Karen A.
    Rathkopf, Dana E.
    Kampel, Lewisj.
    Morris, Michael J.
    Arauz, Gabrielle
    Graf, Ryon P.
    Kelvin, James
    Dittamore, Ryan Vance
    De Leeuw, Renee
    Sullivan, Amanda
    Tse, Kin
    Molina, Ana M.
    Scher, Howard I.
    Kelly, William Kevin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [6] Capture and characterization of circulating tumor cell clusters in patients with metastatic castrate-resistant prostate cancer
    Savitch, Samantha L.
    Yee, Stephanie S.
    Soucier, Devon
    Smirnov, Denis
    Rao, Chandra
    Gross, Steve
    Amaravadi, Ravi K.
    Vaughn, David J.
    Haas, Naomi B.
    Carpenter, Erica L.
    [J]. CANCER RESEARCH, 2017, 77
  • [7] Non-enrichment based method for analysis of androgen receptor expression in circulating tumor cells (CTCs) in patients with metastatic castrate resistant prostate cancer
    Gross, Mitchell E.
    Lazar, Daniel C.
    Cho, Edward H.
    Luttgen, Madelyn
    Uson, Maria L.
    Kuhn, Peter
    Torrey, Melissa L.
    [J]. CANCER RESEARCH, 2012, 72
  • [8] Phenotypic and molecular characterization of circulating tumor cells (CTCs) in patients with castration resistant prostate cancer (CRPC) undergoing treatment with abiraterone acetate or enzalutamide
    Patel, Jaymala
    Bhargava, Vipul
    He, Miaoling
    Foulk, Brad
    Smirnov, Denis A.
    Twardowski, Przemyslaw
    Kortylewski, Marcin
    Pal, Sumanta Kumar
    Jones, Jeremy O.
    [J]. CANCER RESEARCH, 2015, 75
  • [9] Analysis of circulating tumor cells (CTCs) in a phase 3 study of docetaxel and prednisone (DP) with or without lenalidomide (LEN) in patients (pts) with castrate-resistant prostate cancer (CRPC): The MAINSAIL trial
    Vogelzang, N. J.
    Petrylak, D. P.
    Fizazi, K.
    Sternberg, C. N.
    De Wit, R.
    Liu, K.
    Waldman, M.
    Barton, D.
    Jungnelius, U.
    Fandi, A.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S11 - S11
  • [10] Fluorescence-activated cell sorting (FACS) and immunofluorescence (IF) detection and characterization of circulating tumor cells (CTC) from men with castrate-resistant prostate cancer (CRPC)
    Szmulewitz, R. Z.
    Wyche, A. J.
    Posadas, E. M.
    Stadler, W. M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
12345